AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Immunogene Therapy Augments Angiostatin In Murine Model Of Lymphoma.(Brief Article)

Vaccine Weekly

| December 19, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 DEC 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Combining the angiogenesis inhibitor angiostatin and immunogene

therapy with the T-cell costimulator B7.1 not only reduces solid lymphomas, but it also elicits antitumor immunity.

Researchers in New Zealand have used a combination of angiostatin and B7.1 gene therapies to stimulate immune system response against EL-4 lymphomas in mice, suggesting the combination of these two therapies would be an effective tumor vaccine.

According to X.Y. Sun, University of Auckland, New Zealand, angiostatin gene therapy alone generated a weak antitumor response with some antiangiogenic activity in mice implanted with EL-4 lymphomas.

"In contrast, when angiostatin gene therapy was preceded by in situ gene transfer of the T-cell costimulator B7.1, large (0.4 cm in diameter) tumors were rapidly and completely eradicated," Sun and coworkers said, pointing out that neither gene therapy was as effective when used as monotherapy.

In addition, mice challenged with systemic administration of EL-4 cells after receiving combination gene therapy mounted a significant attack against those cells, combating EL-4 cell entrenchment and growth. "Gene transfer of angiostatin expression plasmids led to overexpression of angiostatin in tumors, increased apoptosis of tumor cells, and decreased density of tumor blood vessels, which may have allowed ...

Related articles from newspapers, magazines, journals, and more
FIRST PATIENTS IN NZ GENE THERAPY FOR PARKINSON'S DOING WELL.
News wire article from: Asia Africa Intelligence Wire September 28, 2005 700+ words
(From New Zealand Press Association) Wellington, Sept 28 NZPA - A New Zealand-developed gene therapy for Parkinson's disease has...chemical important for movement. The gene therapy calms certain brain cells whose...
Gene therapy hope for Parkinsons disease.
News wire article from: Europe Intelligence Wire October 11, 2002 700+ words
...disease sufferers with gene therapy for the first time...like condition. In gene therapy, scientists use modified...their muscles. The gene therapy approach, developed...scientists from the US and New Zealand, involves placing a...
Gene therapy hope for Parkinson's disease.
News wire article from: Europe Intelligence Wire October 11, 2002 700+ words
...disease sufferers with gene therapy for the first time...like condition. In gene therapy, scientists use modified...their muscles. The gene therapy approach, developed...scientists from the US and New Zealand, involves placing a...
Gene Therapy Targets Canavan disease.
Magazine article from: The Scientist STEINBERG, DOUGLAS September 17, 2001 700+ words
...function; and gene-therapy efficacy could...FORWARD The first gene-therapy trial on Canavan...During's native New Zealand in 1996. This...controversies in New Zealand and the United...who entered the gene-therapy field as During...
Rare disorder responds to gene therapy.
News wire article from: Milwaukee Journal Sentinel (via Knight-Ridder/Tribune News Service) August 13, 2004 700+ words
...2005 _ is testing how gene therapy can improve the odds...principal investigator of gene therapy for Canavan disease...Eight years ago, in New Zealand, the same group performed the first gene therapy treatment of a genetic...
NEW ZEALAND TRIALS OF LOCALLY ENGINEERED GENE MAY TAKE TWO YEARS.
News wire article from: Asia Africa Intelligence Wire October 23, 2002 700+ words
(From New Zealand Press Association) Wellington, Oct 23 - New Zealand trials of the gene therapy pioneered by Auckland University...During first carried out in New Zealand in 1996 a gene therapy he developed in the United...
Evanston Northwestern Hospital, Department of Pathology publishes research in...
Newspaper article from: Cancer Gene Therapy Week April 20, 2009 700+ words
...cells. MiRNA-based gene therapy provides an attractive...Pathology (see also Cancer Gene Therapy). The researchers...Bay, Auckland 10, New Zealand. Keywords: United...Biotechnology, Cancer Gene Therapy, Oncology, Pathology...
Studies conducted at University of Auckland on gene therapy recently published.
Newspaper article from: Virus Weekly August 26, 2008 700+ words
...Auckland (see also Gene Therapy). The researchers...92019, Auckland 1, New Zealand. Publisher contact...1917, USA. Keywords: New Zealand, Auckland, Adeno...Nervous System Disease, Gene Therapy, Genetics, Genomics...
New Study Shows Efficacy of Gene Therapy for Parkinson's Disease.
Press release article from: Business Wire October 10, 2002 700+ words
...Writers BIOWIRE2K AUCKLAND, New Zealand and NEW YORK--(BUSINESS...Ever Clinical Trials Using Gene Therapy for Parkinson's Disease...the effectiveness of a new gene therapy approach to Parkinson's...first time in the world that gene therapy will be used in patients...
Diet supplements and gene therapy tried for Parkinson's disease. (News).(Brief...
Magazine article from: British Medical Journal Tanne, Janice Hopkins October 19, 2002 700+ words
...supplements and gene therapy--might be...United States and New Zealand said last week...approved the first gene therapy-trial for advanced...approved study of gene therapy for Parkinson...of Auckland, New Zealand, and the Weill...
For more facts and information, see all results

Source: HighBeam Research, Immunogene Therapy Augments Angiostatin In Murine Model Of...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA